S P Wilczynski - JoVE Visualize

Showing results (31-40 of 46) with videos related to

Pageof 5

Sort By:

American Journal of Clinical Pathology|October 1, 1990

The use of molecular probes to distinguish new primary tumors from recurrent tumors in gynecologic malignanciesJ D Bloss, S P Wilczynski, S Y Liao, et al.

Obstetrics and Gynecology|May 1, 1995

Prognostic significance of human papillomavirus DNA in vulvar carcinomaB J Monk, R A Burger, F Lin, et al.

Archives of Otolaryngology--Head & Neck Surgery|November 1, 1993

Chromosome 11Q13 amplification in head and neck squamous cell carcinomaM E Williams, M J Gaffey, L M Weiss, et al.

Human Pathology|July 1, 1991

Clinical and histologic features of vulvar carcinomas analyzed for human papillomavirus status: evidence that squamous cell carcinoma of the vulva has more than one etiologyJ D Bloss, S Y Liao, S P Wilczynski, et al.

Gynecologic Oncology|September 11, 1992

Analysis of fine-needle aspirates for HPV by PCR may be useful in diagnosis of metastatic gynecologic malignanciesC I Macri, N S Cook, J L Walker, et al.

Cancer|August 15, 1993

Mutations of p53 and human papillomavirus infection in cervical carcinomaR L Paquette, Y Y Lee, S P Wilczynski, et al.

Journal of the National Cancer Institute|October 2, 1996

Human papillomavirus type 18: association with poor prognosis in early stage cervical cancerR A Burger, B J Monk, T Kurosaki, et al.

American Journal of Obstetrics and Gynecology|November 1, 1994

Correlation of C-myc and HER-2/neu amplification and expression with histopathologic variables in uterine corpus cancerB J Monk, J A Chapman, G A Johnson, et al.

Cancer Genetics and Cytogenetics|July 17, 1998

Loss of heterozygosity in squamous cell carcinomas of the head and neck defines a tumor suppressor gene region on 11q13M Venugopalan, T F Wood, S P Wilczynski, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 9, 2007

Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)D S Alberts, P Y Liu, S P Wilczynski, et al.

Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:

Pageof 5

American Journal of Clinical Pathology|October 1, 1990

The use of molecular probes to distinguish new primary tumors from recurrent tumors in gynecologic malignanciesJ D Bloss, S P Wilczynski, S Y Liao, et al.

Obstetrics and Gynecology|May 1, 1995

Prognostic significance of human papillomavirus DNA in vulvar carcinomaB J Monk, R A Burger, F Lin, et al.

Archives of Otolaryngology--Head & Neck Surgery|November 1, 1993

Chromosome 11Q13 amplification in head and neck squamous cell carcinomaM E Williams, M J Gaffey, L M Weiss, et al.

Human Pathology|July 1, 1991

Clinical and histologic features of vulvar carcinomas analyzed for human papillomavirus status: evidence that squamous cell carcinoma of the vulva has more than one etiologyJ D Bloss, S Y Liao, S P Wilczynski, et al.

Gynecologic Oncology|September 11, 1992

Analysis of fine-needle aspirates for HPV by PCR may be useful in diagnosis of metastatic gynecologic malignanciesC I Macri, N S Cook, J L Walker, et al.

Cancer|August 15, 1993

Mutations of p53 and human papillomavirus infection in cervical carcinomaR L Paquette, Y Y Lee, S P Wilczynski, et al.

Journal of the National Cancer Institute|October 2, 1996

Human papillomavirus type 18: association with poor prognosis in early stage cervical cancerR A Burger, B J Monk, T Kurosaki, et al.

American Journal of Obstetrics and Gynecology|November 1, 1994

Correlation of C-myc and HER-2/neu amplification and expression with histopathologic variables in uterine corpus cancerB J Monk, J A Chapman, G A Johnson, et al.

Cancer Genetics and Cytogenetics|July 17, 1998

Loss of heterozygosity in squamous cell carcinomas of the head and neck defines a tumor suppressor gene region on 11q13M Venugopalan, T F Wood, S P Wilczynski, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 9, 2007

Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)D S Alberts, P Y Liu, S P Wilczynski, et al.

Pageof 5